The findings reach mice, none yet in people; independent labs found the same change in mice. 7 independent labs in 6 countries; 8 trials, 5 with no results posted.
None of its findings points the other way.
Mice: replicated by independent labs. Cells, worms or flies and humans: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
No results posted: trials that ended over a year ago with no results on ClinicalTrials.gov and no paper reporting them.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
7 independent labs in 6 countries
8 trials, 5 with no results posted
Funders: Emberi Eroforrások Minisztériuma and others
2 of 18 findings with company ties
What did studies of streptozotocin find?
17
Studies of streptozotocin measured 17 outcomes, among them cellular senescence, senescence-associated secretory phenotype (SASP) and ER unfolded protein response.
Cellular senescence
↑upin rats2
2 studies
Streptozotocin induces cellular senescence in rats (measured by p53, p21 and p16 in cultured astrocytes from STZ-ICV-treated rats).
“When evaluating senescence parameters, increases in p53, p21, and p16 were observed”
Animalsmeasured by p53, p21 and p16 in cultured astrocytes from STZ-ICV-treated ratshypothalamic astrocytesfour weeksmales
Streptozotocin increases cellular senescence in DKD rats.
“In DKD rats and HK-2 cells, p21, p53, LC3 and p62 expression levels were higher than in the controls, as were SA-β-gal-positive cells, renal tubular autophagosomes”
Experiments in mice with diabetes-induced kidney disease found less kidney tubule cell senescence, a state in which cells stop dividing, after receiving procyanidin C1.Experiments in mice with diabetes-induced kidney disease found less kidney tubule cell senescence, a state in which cells stop dividing, after receiving procyanidin C1.
At the acute endpoint, efsubaglutide alfa raised heart rate to 372.76 beats per minute versus 312.64 in rats with pacemaker dysfunction without the drug.At the acute endpoint, efsubaglutide alfa raised heart rate to 372.76 beats per minute versus 312.64 in rats with pacemaker dysfunction without the drug.